research updates

Doctors and researchers met online to discuss how the coronavirus pandemic changed cancer care in its early months, as well as how they can improve care and advocate for patients going forward.

by Kate Yandell

Delays in cancer screening and diagnosis due to the COVID-19 pandemic put people at risk.

by Kevin McLaughlin

From the Editor-In-Chief

Surrogate endpoints can speed up drug approvals, but are they valid measures of effectiveness?

by William G. Nelson, MD, PhD

Forward Look

Christine Ambrosone on what her research shows.

by Sue Rochman

Forward Look

As patents expire on biologic drugs, cancer patients get new options.

by Stephen Ornes

Forward Look

Targeted therapy approvals increase options and hope for some patients.

by Cameron Walker

Forward Look

Experts say it’s necessary to look behind the statistics.

by Delia O’Hara

FORWARD LOOK

A new way to identify a cancer recurrence.

by Bradley Jones

Policy Matters

The AACR and the FDA presented joint recommendations that include broadening clinical trial eligibility and engaging the community in clinical trial recruitment.

by Kenneth C. Anderson, MD; Lola A. Fashoyin-Aje, MD, MPH; Nicole Gormley, MD; and Paul G. Kluetz, MD

Healthy Habits

Drinking at any level increases cancer risk.

by Ashley P. Taylor